Sylvie Nathanson Selected Research

Sylvie Nathanson Research Topics

4	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2021 - 12/2002
2	Proteinuria 11/2006 - 12/2005
1	Chickenpox 03/2022
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2021
1	COVID-19 07/2020
1	Infections 07/2020
1	Aseptic Meningitis 10/2019
1	Deglutition Disorders (Dysphagia) 01/2019
1	Asthma (Bronchial Asthma) 01/2018
1	Pyelonephritis 09/2016
1	Cystitis 09/2016
1	Inflammation (Inflammations) 09/2016
1	Leukocytosis (Pleocytosis) 09/2016
1	Neurologic Manifestations (Neurological Manifestations) 07/2010
1	Acute Kidney Injury (Acute Renal Failure) 07/2010
1	Renal Insufficiency (Renal Failure) 11/2006
1	Complement Factor H Deficiency 11/2006
1	Hypertension (High Blood Pressure) 11/2006
1	Burkitt Lymphoma (Burkitt's Lymphoma) 12/2002
1	Neoplasms (Cancer) 12/2002
1	Cerebellar Diseases (Cerebellar Syndrome) 12/2002

3	Biological ProductsIBA 07/2020 - 11/2006
1	Acyclovir (Aciclovir)FDA LinkGeneric 03/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	daratumumabIBA 01/2021
1	obinutuzumabIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 07/2020
1	ProcalcitoninIBA 10/2019
1	TabletsIBA 01/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	Rituximab (Mabthera)FDA Link 06/2013
1	SteroidsIBA 06/2013
1	CreatinineIBA 11/2006
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2006
1	HaptoglobinsIBA 11/2006
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2006
1	Complement Factor H (Factor H)IBA 11/2006
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2005
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2005
1	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2002

3	Therapeutics 01/2018 - 12/2005
2	Plasma Exchange 07/2010 - 12/2005
2	Kidney Transplantation 12/2005 - 12/2002
1	Peritoneal Dialysis 07/2010
1	Renal Dialysis (Hemodialysis) 07/2010
1	Nephrectomy 11/2006
1	Combination Drug Therapy (Combination Chemotherapy) 12/2002